IMPORTANT UPDATES

To submit a grant request you must first be registered in the Request Management System (RMS).

Using Google Chrome or Firefox, go here to register:  https://webportalapp.com/sp/login/teva-registration.

Once your registration is approved, you will receive an email from the RMS with the submission link (https://webportalapp.com/sp/login/teva-grantrequest) and you will be able to submit a request.

 

For refund checks, please note the new address to submit:Teva Pharmaceuticals, Attention: Medical Education Department, 400 Interpace Parkway, #3, Parsippany, NJ 07054

For any inquiries email: tevarequestmanagement@tevapharm.com or call 800-961-3604. Please include the grant number if applicable.

 

important

Education Objectives: Migraine

  • Support education to improve HCP’s knowledge and competency in their understanding of therapeutic monoclonal antibodies
  • Support education to improve HCP’s knowledge and competency in their understanding of migraine as a DISEASE, its symptoms and clinical features, and the immunologic/pathogenic mechanisms of Calcitonin Gene-Related Peptide (CGRP) in migraine
  • Support education and scientific exchange regarding peer reviewed, published clinical data in headache disorders
  • Support education and scientific exchange regarding the diagnosis of episodic and chronic migraine and the recognition of appropriate patients for preventive treatments
  • Support education and scientific exchange regarding issues of persistence and adherence to migraine medications
  • Support education to improve HCP’s awareness and knowledge of the socioeconomic burden of migraine
  • Support education to improve HCP’s awareness and knowledge of patients with difficult-to-treat migraine
  • Support education to facilitate team-based learning and communication between all clinicians involved with the care of patients suffering with migraine
  • Support educational programs that facilitate the continuing professional development of medical students or residents

Migraine Audience Groups:   Primary Care Physicians, Neurologists, Headache Specialists, Pain Specialists, Nurse Practitioners, Physician Assistants, Psychiatrists, Nurses, OB-GYN, Pharmacists, medical students, residents

Education Objectives: Huntington's Disease

    • Support education to improve knowledge and awareness of Huntington’s Disease, including genetic factors, disease state pathophysiology, symptoms, and diagnosis of patients, quality of life, psychological issues and movement issues
    • Support education to improve knowledge and awareness of the clinical efficacy and safety profile of current and potential treatment options for Huntington’s Disease
    • Support education to improve knowledge and awareness of Huntington’s Disease-related chorea and the ability to identify appropriate patients for treatment, and to improve clinical experience and address unmet treatment needs

Huntington's Disease Audience Groups: Neurologists, Psychiatrists, Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists

Education Objectives: Tardive Dyskinesia

  • Support education to improve knowledge and awareness of Tardive Dyskinesia, including disease state pathophysiology, symptom recognition, diagnosis of patients and quality of life
  • Support education to improve understanding of differential diagnosis of Hyperkinetic Movement disorders
  • Support education to improve knowledge and awareness of conditions and medications known to be associated with Tardive Dyskinesia
  • Support education to improve knowledge and awareness of the clinical efficacy and safety profile of current and potential treatment options for Tardive Dyskinesia
  • Support education to increase confidence in treating Tardive Dyskinesia including monitoring, managing medication adherence, and improving clinical experience on long term treatment and challenges for optimal outcomes
  • Support education to increase competency and confidence in addressing barriers to long-term treatment success with VMAT2 inhibitors and in making appropriate dose adjustments for optimal VMAT2 inhibitor efficacy, safety and medication adherence

Tardive Dyskinesia Audience Groups: Psychiatrists, Neurologists, Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists

Education Objectives: Asthma

Support programs for Asthma that:

  • Increase HCP awareness and understanding regarding poor inhaler technique and potential clinical outcomes
  • Increase HCP understanding of the correlation between overuse of rescue and asthma control
  • Improve HCP competence in identifying patients who are at risk for uncontrolled asthma and asthma exacerbation due to improper inhaler technique and/or poor adherence
  • Increase HCP awareness on the use of digital health and technology in the management of asthma
  • Increase HCP understanding of how digital technology (e.g., SABA tracking, medication use reminders, symptom recording, inhalation feedback, asthma action plans, etc.) can make an impact on inhaler technique and outcomes in asthma
  • Increase awareness of the need for connected/digital respiratory technology and how this might be integrated into everyday patient care

Asthma Audience Groups: Allergists, Pulmonologists, Immunologists, Primary Care Physicians, Nurses, Pharmacists, Nurse Practitioners, and Physician Assistants

Education Objectives: Schizophrenia

  • Support education to improve knowledge of schizophrenia including disease recognition, progression, and burden of disease
  • Support education to increase awareness and understanding of the clinical efficacy and safety profile of current and emerging schizophrenia treatment options including those with different routes of administration
  • Support education to increase competence in optimizing the treatment of schizophrenia including starting treatment, patient monitoring, and switching treatments
  • Support education to increase awareness of the need to provide early, uninterrupted and comprehensive treatment for schizophrenia 

Schizophrenia Audience Groups:  Psychiatrists, Psychiatric NPs, Psychiatric PAs, Psychiatric Nurses, Psychiatric Pharmacists